Laparoscopic appendectomy for acute appendicitis: How to discourage surgeons using inadequate therapy

World J Gastroenterol. 2017 Aug 28;23(32):5849-5859. doi: 10.3748/wjg.v23.i32.5849.

Abstract

Acute appendicitis (AA) develops in a progressive and irreversible manner, even if the clinical course of AA can be temporarily modified by intentional medications. Reliable and real-time diagnosis of AA can be made based on findings of the white blood cell count and enhanced computed tomography. Emergent laparoscopic appendectomy (LA) is considered as the first therapeutic choice for AA. Interval/delayed appendectomy at 6-12 wk after disease onset is considered as unsafe with a high recurrent rate during the waiting time. However, this technique may have some advantages for avoiding unnecessary extended resection in patients with an appendiceal mass. Non-operative management of AA may be tolerated only in children. Postoperative complications increase according to the patient's factors, and temporal avoidance of emergent general anesthesia may be beneficial for high-risk patients. The surgeon's skill and cooperation of the hospital are important for successful LA. Delaying appendectomy for less than 24 h from diagnosis is safe. Additionally, a semi-elective manner (i.e., LA within 24 h after onset of symptoms) may be paradoxically acceptable, according to the factors of the patient, physician, and institution. Prompt LA is mandatory for AA. Fortunately, the Japanese government uses a universal health insurance system, which covers LA.

Keywords: Acute appendicitis; Delayed appendectomy; Interval appendectomy; Laparoscopic appendectomy; Surgery.

Publication types

  • Review

MeSH terms

  • Adult
  • Age Factors
  • Anesthesia, General / adverse effects
  • Anti-Bacterial Agents / therapeutic use*
  • Appendectomy / adverse effects
  • Appendectomy / economics
  • Appendectomy / methods*
  • Appendicitis / blood
  • Appendicitis / diagnosis
  • Appendicitis / economics
  • Appendicitis / therapy*
  • Biomarkers / blood
  • Child
  • Clinical Competence
  • Colonoscopy
  • Humans
  • Japan
  • Laparoscopy / adverse effects
  • Laparoscopy / economics
  • Laparoscopy / methods*
  • Leukocyte Count
  • Postoperative Complications / epidemiology
  • Postoperative Complications / etiology
  • Surgeons / education
  • Time Factors
  • Tomography, X-Ray Computed
  • Universal Health Insurance

Substances

  • Anti-Bacterial Agents
  • Biomarkers